China

Trump-Xi call on tariffs, Circle’s soaring IPO, Lululemon cuts outlook, and more news to start your day.

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be worth up to $25 billion.

Investment advisors weigh in with the market moves they are making in the trade-war era.

Global diversification is working this year and could continue to do so for years to come.

Investors shouldn’t get their hopes up about the talks.

Causeway’s Sarah Ketterer likes AstraZeneca and Gucci’s parent company, Kering. Where else she’s picking up bargains.

It’s hard to know if Trump's comments on Xi Jinping suggest the world’s two biggest economies are getting any closer to a deal on tariffs.

Despite the harsh rhetoric, both countries need each other for now when it comes to trade.

With a legal challenge to most of its current tariffs, the Trump administration is exploring different mechanisms to impose trade restrictions.

The Chinese electric-vehicle maker posts a per-share loss of 45 cents from sales of $1.7 billion. Wall Street was looking for a loss of 35 cents from sales of $1.7 billion.

Gavekal Founding Partner and Head of Research Arthur Kroeber notes, “The overall objectives of the trade aggression...are as muddled as ever.

NIO, XPeng, and Li Auto delivered almost 98,000 cars in May, up about 50% from a year ago. BYD delivered more than 200,000 all-electric vehicles, up 40% from last year.

China’s economic future increasingly hinges on the spending power of the population living outside the country’s wealthiest urban areas.

A spokesman for the Chinese embassy urged Washington to “jointly uphold the consensus reached at the high-level talks in Geneva.”

The trial was meant to answer the biggest question in biotech: What happens when U.S. companies test promising new Chinese cancer immunotherapies in western countries?

The chip design software firm says it has received notice from the U.S. Commerce Department restricting its sales in China.

Li Auto reports first-quarter earnings per share of 7 cents. Wall Street was looking for 9 cents.

The State Department’s move is the latest in a string of measures targeting universities.

Stocks appeared to welcome the news, with S&P 500 futures jumping 1.4% late Wednesday.

Shares of semiconductor software design companies Cadence and Synopsys fell hard on the news.

Apple rises after tumbling Friday when President Donald Trump threatened a 25% tariff on iPhones sold in the U.S. that are made overseas, while Tesla trades higher even as the electric-vehicle maker’s sales in Europe decline for a fourth straight month.

DeepSeek triggered a wave of market enthusiasm for Chinese artificial-intelligence when it shocked the market with its AI model in January. Here's what has happened since then.

China's leading EV maker BYD announced price cuts to many of its models over the weekend, triggering fears of an intensifying price war.

The company is in the crosshairs of President Donald Trump’s tariffs on imports, particularly from China, which specializes in producing goods at low cost.

Xiaomi recently launched a new electronic vehicle that takes aim at Tesla’s most popular car, the Model Y.